| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.59B | 55.64B | 38.29B | 44.32B | 40.00B | 31.59B |
| Gross Profit | 30.99B | 27.14B | 17.10B | 20.23B | 17.02B | 10.28B |
| EBITDA | 17.73B | 14.85B | 7.71B | 12.56B | 10.63B | 4.25B |
| Net Income | 9.90B | 8.81B | 4.13B | 7.53B | 8.24B | 1.50B |
Balance Sheet | ||||||
| Total Assets | 81.63B | 79.99B | 55.85B | 54.38B | 49.74B | 37.87B |
| Cash, Cash Equivalents and Short-Term Investments | 16.46B | 23.95B | 17.99B | 21.55B | 19.20B | 12.10B |
| Total Debt | 6.61B | 1.18B | 1.34B | 1.27B | 1.33B | 1.53B |
| Total Liabilities | 29.63B | 30.34B | 14.65B | 15.75B | 16.68B | 13.45B |
| Stockholders Equity | 52.00B | 49.64B | 41.20B | 38.63B | 33.06B | 24.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.06B | -1.53B | 4.55B | 4.23B | 1.27B |
| Operating Cash Flow | 0.00 | 15.10B | 4.84B | 8.39B | 7.38B | 3.55B |
| Investing Cash Flow | 0.00 | -7.83B | -7.50B | -2.27B | -1.94B | -3.05B |
| Financing Cash Flow | 0.00 | -1.44B | -2.17B | -2.48B | -1.25B | -483.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥184.21B | 18.45 | ― | 3.09% | 14.85% | 29.86% | |
76 Outperform | ¥85.48B | 16.80 | ― | 4.31% | 4.77% | -36.62% | |
75 Outperform | ¥137.98B | 13.42 | ― | 2.45% | 4.60% | -21.64% | |
67 Neutral | ¥297.68B | 29.54 | ― | 1.02% | 29.60% | 24.39% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥130.37B | 113.57 | ― | ― | -51.82% | -96.08% |